Monday, December 1, 2014
OncoMed Begins Patient Dosing in Phase 2 Clinical Trial of Tarextumab (Anti-Notch 2/3, OMP-59R5) in Small Cell Lung Cancer
… Small Cell Lung Cancer
According to the American Cancer Society, lung cancer (both small … Untreated Extensive Stage Small Cell Lung Cancer) is testing tarextumab in combination … first-line extensive stage small cell lung cancer patients. Tarextumab is part of …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment